V

Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800

Watchlist Manager
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Watchlist
Price: 4 590 KRW 13.33% Market Closed
Market Cap: 230B KRW
Section:
 

Relative Value

The Relative Value of one Vivozon Pharmaceutical Co Ltd stock under the Base Case scenario is 5 505.41 KRW. Compared to the current market price of 4 590 KRW, Vivozon Pharmaceutical Co Ltd is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
5 505.41 KRW
Undervaluation 17%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

2.7
P/S
P/S
Price to Sales
2.7
vs History
77
vs Industry
39
Median 3Y
2.9
Median 5Y
4
Industry
3.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-21.5
Industry
30.7
More Details
137.1
P/OCF
P/OCF
Price to OCF
137.1
vs History
19
vs Industry
15
Median 3Y
47.6
Median 5Y
40.6
Industry
19.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-12.6
Median 5Y
-18
Industry
26
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
66
vs Industry
31
Median 3Y
2
Median 5Y
3.3
Industry
2.7
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
77
vs Industry
37
Median 3Y
3
Median 5Y
4.1
Industry
3.8
More Details
5.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.3
vs History
84
vs Industry
51
Median 3Y
7
Median 5Y
8.5
Industry
12.5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
16
Median 3Y
-11.2
Median 5Y
-60
Industry
19.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
11
Median 3Y
-9.9
Median 5Y
-45.8
Industry
25.9
More Details
140.5
EV/OCF
EV/OCF
Enterprise Value to OCF
140.5
vs History
19
vs Industry
15
Median 3Y
47.4
Median 5Y
41
Industry
19.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-35.8
Median 5Y
-40.9
Industry
25.4
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
66
vs Industry
40
Median 3Y
1.4
Median 5Y
2.3
Industry
2.2
More Details

Multiples Across Competitors

Competitors Multiples
Vivozon Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
227.4B KRW 2.7 -13.8 -407.5 -51.8
US
NVIDIA Corp
NASDAQ:NVDA
4.6T USD 24.5 46.3 40.1 41
US
Broadcom Inc
NASDAQ:AVGO
1.6T USD 25.8 71.3 48.5 64.8
TW
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
41.1T TWD 11.3 25.9 15.8 21.8
US
Advanced Micro Devices Inc
NASDAQ:AMD
362.7B USD 11.3 109.7 61.5 127.2
US
Micron Technology Inc
NASDAQ:MU
355.2B USD 8.4 29.8 16 25.9
KR
SK Hynix Inc
KRX:000660
467.4T KRW 5.6 13.1 9.2 12.7
US
Intel Corp
NASDAQ:INTC
187.7B USD 3.5 947.9 17.9 -1 930.8
US
Qualcomm Inc
NASDAQ:QCOM
185.8B USD 4.2 33.5 13.6 15.4
US
Texas Instruments Inc
NASDAQ:TXN
161.4B USD 9.3 32.2 21.5 28.2
US
Analog Devices Inc
NASDAQ:ADI
134B USD 12.2 59.1 27.8 46.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
V
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Average EV/EBIT: 42.6
Negative Multiple: -51.8 		N/A N/A
US
NVIDIA Corp
NASDAQ:NVDA
41
51%
0.8
US
Broadcom Inc
NASDAQ:AVGO
64.8
55%
1.2
TW
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
21.8
29%
0.8
US
Advanced Micro Devices Inc
NASDAQ:AMD
127.2
111%
1.1
US
Micron Technology Inc
NASDAQ:MU
25.9
75%
0.3
KR
SK Hynix Inc
KRX:000660
12.7
52%
0.2
US
Intel Corp
NASDAQ:INTC
Negative Multiple: -1 930.8 N/A N/A
US
Qualcomm Inc
NASDAQ:QCOM
15.4
8%
1.9
US
Texas Instruments Inc
NASDAQ:TXN
28.2
16%
1.8
US
Analog Devices Inc
NASDAQ:ADI
46.3
34%
1.4

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.